Care

Eli Lilly Bets $2.8 Billion on Psychedelic Mental Health
Care Eli Lilly Bets $2.8 Billion on Psychedelic Mental Health

The global mental health landscape is undergoing a tectonic shift as traditional pharmaceutical giants pivot toward neuro-reductive therapies that were once relegated to the fringes of medical science. With treatment-resistant depression and post-traumatic stress disorder affecting millions of

Bolton’s Best and Worst GP Practices Ranked in New Survey
Care Bolton’s Best and Worst GP Practices Ranked in New Survey

The fundamental quality of healthcare within a community often serves as the most reliable indicator of overall public well-being and social stability for the residents living there. In Bolton, the release of the 2026 GP Patient Survey has provided a transparent and detailed map of the current

How Is SkyBridge Reshaping Medical Logistics in Thailand?
Care How Is SkyBridge Reshaping Medical Logistics in Thailand?

In the rugged mountainous terrain of northern Thailand, where monsoon-induced landslides frequently sever vital road links, the speed of medical intervention has historically been dictated by geography rather than clinical urgency. This geographical reality has often left remote communities

Will Missouri Tax Healthcare to End the Income Tax?
Care Will Missouri Tax Healthcare to End the Income Tax?

Missouri stands at a monumental crossroads as state legislators debate a fundamental transformation of the revenue collection system that could redefine the local economy. The proposal centers on a constitutional amendment that would empower the General Assembly to abolish the state’s personal i

Is the Scale Failing Patients in the GLP-1 Era?
Care Is the Scale Failing Patients in the GLP-1 Era?

The rapid medicalization of weight management through GLP-1 receptor agonists has fundamentally altered the clinical understanding of obesity, shifting the discourse away from simple behavioral changes toward the complex hormonal regulation of human metabolic health. This pharmaceutical revolution

Can This New Liver Cancer Therapy Finally Win FDA Approval?
Care Can This New Liver Cancer Therapy Finally Win FDA Approval?

The landscape of oncology has often been defined by the grueling pursuit of therapies that can extend survival for patients with late-stage hepatocellular carcinoma, a disease where traditional treatment options have frequently reached their limits. For HLB and its American subsidiary, Elevar

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later